Home / Arts and Entertainment / Michael J. Fox: Parkinson's Research Transformed
Michael J. Fox: Parkinson's Research Transformed
24 Jul
Summary
- Michael J. Fox Foundation funded over $3 billion in research.
- 180 Parkinson's drug programs are now in human testing.
- Acting on 'Shrinking' has prolonged and enriched his life.

Michael J. Fox has significantly transformed Parkinson's research, with his foundation having funded over $3 billion in scientific endeavors. This substantial investment has dramatically reshaped the landscape, moving from a time when few treatments reached human trials to today's 180 active Parkinson's drug programs undergoing human testing. This progress is a direct result of dedicated research over the past two decades.
Fox's own journey with Parkinson's disease, diagnosed in 1991 at age 29, has been marked by a decision to openly share his experience. He chose to 'not hide this' to normalize the condition and support others, despite the challenges it presented for his family. This dedication has been ongoing for over 35 years, a unique commitment among Parkinson's patients.
Returning to acting, notably in 'Shrinking' where he played a character with Parkinson's alongside Harrison Ford, has been personally rewarding for Fox. He stated that acting has truly prolonged his life and added a layer of interest he hadn't anticipated. While he is not officially retired, he acknowledges Parkinson's influences his career decisions.